The iLA membrane ventilator is an extrapulmonary ventilation system which is used to remove carbon dioxide. The heart pumps blood through the iLA membrane ventilator as it does through a natural organ.
The iLA membrane ventilator “breathes” outside of the body for the patient and carries out some of the gas exchange work of the native lung.
The gas exchange takes place via a plasma-tight, heparin-coated diffusion membrane which is connected arteriovenously femorally by means of two NovaPort one KI single lumen cannulas. This makes the iLA membrane ventilator the world’s only available pumpless extrapulmonary gas exchange system.
The iLA membrane ventilator is designed specially for long-term use, and can be applied to the patient for up to 29 days.
• Reliable efficacy – efficient CO2 removal
• x.ellence, a multi-layer coating for stable bio- and hemocompatible surfaces
• Easy handling
• One vascular access for iLA membrane ventilator and CRRT thanks to integrated CRRT connector"
For your information: Not all products are cleared or available for sale in all countries. For further information on country-specific regulations, please contact your local Xenios AG representative.
Also, this information is not intended for an audience within the USA. If your are from the USA, please visit the corresponding Fresenius Medical Care website here.
Women's Health Community Supported by Hologic
Comprehensive information on women’s health issues and management, management and personalisation.
Enterprise Imaging Community
Advanced and scalable radiology solutions that can help improve care coordination, increase speed and facilitate accurate clinical decisions.
Decision Support Community Supported by Siemens Healthineers
Leading the way in highlighting useful and efficient decision support tools for improved patient outcomes.
Sepsis Community Supported by Abionic
Addressing the latest developments in sepsis and providing clinically useful information for diagnosis and treatment of patients.
COVID-19 Vaccines Prevented 20 Million Deaths Worldwide
Findings from the first modelling study to quantify the impact of COVID-19... Read more
Omicron Has Half the Risk of Long COVID Compared to Delta
New research shows that the Omicron variant is less likely to cause Long-COVID... Read more
JOIN OUR MANAGEMENT COMMUNITY